Hochschulschrift
Modifying the immunogenicity of AAV vectors for gene therapy and cancer immunotherapy
- Weitere Titel
-
Adeno-associated virus
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
241 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Hannover Medical School, Dissertation, 2022
- Ereignis
-
Veröffentlichung
- (wo)
-
Hannover
- (wann)
-
September 2022
- Urheber
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 11:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- September 2022
Ähnliche Objekte (12)
Adeno-Associated Virus (AAV) vectors in gene therapy
Generation and characterization of AAV vectors for combination immunotherapy against HIV-1
Disease modifying therapy in vasculitides
Engineering AAV-2 targeting vectors : a new insertion site and scFv driven vectors
Engineering AAV-2 targeting vectors : a new insertion site and scFv driven vectors
Recombinant AAV Vectors for Enhanced Expression of Authentic IgG
Modifying enzyme replacement therapy – a perspective
Targeted local combination therapy with checkpoint inhibitors and CAR-NK cells in glioblastoma using DARPin-linked AAV vectors
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Receptor-targeted viral vectors: Tracking of stem cells and side by side comparison of AAV and lentiviral vectors
Receptor-targeted viral vectors : tracking of stem cells and side by side comparison of AAV and lentiviral vectors
Retro-vectors for human gene therapy
Adeno-Associated Virus (AAV) vectors in gene therapy
Generation and characterization of AAV vectors for combination immunotherapy against HIV-1
Disease modifying therapy in vasculitides
Engineering AAV-2 targeting vectors : a new insertion site and scFv driven vectors
Engineering AAV-2 targeting vectors : a new insertion site and scFv driven vectors
Recombinant AAV Vectors for Enhanced Expression of Authentic IgG
Modifying enzyme replacement therapy – a perspective
Targeted local combination therapy with checkpoint inhibitors and CAR-NK cells in glioblastoma using DARPin-linked AAV vectors
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Receptor-targeted viral vectors: Tracking of stem cells and side by side comparison of AAV and lentiviral vectors
Receptor-targeted viral vectors : tracking of stem cells and side by side comparison of AAV and lentiviral vectors
Retro-vectors for human gene therapy
Adeno-Associated Virus (AAV) vectors in gene therapy
Generation and characterization of AAV vectors for combination immunotherapy against HIV-1
Disease modifying therapy in vasculitides
Engineering AAV-2 targeting vectors : a new insertion site and scFv driven vectors
Engineering AAV-2 targeting vectors : a new insertion site and scFv driven vectors
Recombinant AAV Vectors for Enhanced Expression of Authentic IgG
Modifying enzyme replacement therapy – a perspective
Targeted local combination therapy with checkpoint inhibitors and CAR-NK cells in glioblastoma using DARPin-linked AAV vectors
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Receptor-targeted viral vectors: Tracking of stem cells and side by side comparison of AAV and lentiviral vectors
Receptor-targeted viral vectors : tracking of stem cells and side by side comparison of AAV and lentiviral vectors